vs
Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Zedge, Inc. (ZDGE). Click either name above to swap in a different company.
Zedge, Inc. is the larger business by last-quarter revenue ($7.6M vs $3.9M, roughly 2.0× Opus Genetics, Inc.). On growth, Zedge, Inc. posted the faster year-over-year revenue change (5.8% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -1.0%).
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
Zedge is a content distribution platform that provides consumers with a way to personalize their mobile devices. It has offices in Trondheim, Vilnius, and New York City.
IRD vs ZDGE — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $7.6M |
| Net Profit | — | $788.0K |
| Gross Margin | — | — |
| Operating Margin | — | 12.0% |
| Net Margin | — | 10.4% |
| Revenue YoY | -10.2% | 5.8% |
| Net Profit YoY | 53.0% | 332.4% |
| EPS (diluted) | — | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $7.6M | ||
| Q3 25 | $3.1M | $7.5M | ||
| Q2 25 | $2.9M | $7.8M | ||
| Q1 25 | $4.4M | $7.0M | ||
| Q4 24 | $4.3M | $7.2M | ||
| Q3 24 | $3.9M | $7.6M | ||
| Q2 24 | $1.1M | $7.7M | ||
| Q1 24 | $1.7M | $7.8M |
| Q4 25 | — | $788.0K | ||
| Q3 25 | $-17.5M | $-559.0K | ||
| Q2 25 | $-7.4M | $185.0K | ||
| Q1 25 | $-8.2M | $-1.7M | ||
| Q4 24 | — | $-339.0K | ||
| Q3 24 | $-7.5M | $-39.0K | ||
| Q2 24 | $-7.8M | $113.0K | ||
| Q1 24 | $-7.1M | $-9.2M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | -269.9% | -9.6% | ||
| Q2 25 | -309.0% | 2.1% | ||
| Q1 25 | -227.2% | -31.8% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | -207.1% | -0.8% | ||
| Q2 24 | -748.9% | -1.7% | ||
| Q1 24 | -450.5% | -153.5% |
| Q4 25 | — | 10.4% | ||
| Q3 25 | -566.9% | -7.5% | ||
| Q2 25 | -257.5% | 2.4% | ||
| Q1 25 | -187.5% | -24.1% | ||
| Q4 24 | — | -4.7% | ||
| Q3 24 | -194.6% | -0.5% | ||
| Q2 24 | -698.3% | 1.5% | ||
| Q1 24 | -415.3% | -118.8% |
| Q4 25 | — | $0.06 | ||
| Q3 25 | $-0.25 | $-0.04 | ||
| Q2 25 | $-0.12 | $0.01 | ||
| Q1 25 | $-0.24 | $-0.12 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $-0.29 | $0.00 | ||
| Q2 24 | $-0.30 | $0.01 | ||
| Q1 24 | $-0.29 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.1M | $18.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.3M | $25.9M |
| Total Assets | $50.2M | $36.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $18.5M | ||
| Q3 25 | $30.8M | $18.6M | ||
| Q2 25 | $32.4M | $20.4M | ||
| Q1 25 | $41.8M | $20.1M | ||
| Q4 24 | $30.3M | $20.2M | ||
| Q3 24 | $36.6M | $20.0M | ||
| Q2 24 | $41.4M | $19.9M | ||
| Q1 24 | $47.2M | $18.1M |
| Q4 25 | $15.3M | $25.9M | ||
| Q3 25 | $6.0M | $25.9M | ||
| Q2 25 | $17.5M | $28.6M | ||
| Q1 25 | $5.1M | $28.2M | ||
| Q4 24 | $6.7M | $30.1M | ||
| Q3 24 | $34.3M | $30.9M | ||
| Q2 24 | $40.6M | $30.9M | ||
| Q1 24 | $46.1M | $30.7M |
| Q4 25 | $50.2M | $36.0M | ||
| Q3 25 | $36.1M | $35.7M | ||
| Q2 25 | $38.7M | $37.8M | ||
| Q1 25 | $48.2M | $37.1M | ||
| Q4 24 | $36.9M | $38.2M | ||
| Q3 24 | $40.4M | $38.2M | ||
| Q2 24 | $44.8M | $38.1M | ||
| Q1 24 | $51.8M | $37.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-35.3M | $825.0K |
| Free Cash FlowOCF − Capex | — | $808.0K |
| FCF MarginFCF / Revenue | — | 10.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 1.05× |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-35.3M | $825.0K | ||
| Q3 25 | $-6.2M | $674.0K | ||
| Q2 25 | $-10.3M | $870.0K | ||
| Q1 25 | $-9.0M | $708.0K | ||
| Q4 24 | $-25.6M | $1.2M | ||
| Q3 24 | $-5.1M | $695.0K | ||
| Q2 24 | $-7.3M | $2.3M | ||
| Q1 24 | $-5.7M | $1.6M |
| Q4 25 | — | $808.0K | ||
| Q3 25 | — | $640.0K | ||
| Q2 25 | — | $851.0K | ||
| Q1 25 | — | $689.0K | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $683.0K | ||
| Q2 24 | — | $2.3M | ||
| Q1 24 | — | $1.6M |
| Q4 25 | — | 10.6% | ||
| Q3 25 | — | 8.6% | ||
| Q2 25 | — | 11.0% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | 30.4% | ||
| Q1 24 | — | 20.0% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | 1.05× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.70× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 20.73× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRD
Segment breakdown not available.
ZDGE
| Zedge Marketplace | $7.1M | 94% |
| Other | $468.0K | 6% |
